🔎 Trials Near Me

Početna › Melanom › Ohio › Cincinnati

Kliničke studije za Melanom u gradu Cincinnati, OH

17 studija za Melanom traži sudionike na lokacijama u gradu Cincinnati i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • i još 3
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

U tijeku regrutacijaFaza 3
  • Oncology Hematology Care Clinical Trials, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

U tijeku regrutacijaFaza 3
  • Oncology Hematology Care, Cincinnati
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

U tijeku regrutacijaFaza 3
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • TriHealth Cancer Institute-Westside, Cincinnati
  • i još 1
Od 75 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

U tijeku regrutacijaFaza 2
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

U tijeku regrutacijaFaza 1/2
  • University of Cincinnati Medical Center, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07287917

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

U tijeku regrutacijaFaza 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

Project: Every Child for Younger Patients With Cancer

U tijeku regrutacijaOpažajna studija
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

U tijeku regrutacijaFaza 1/2
  • University of Cincinnati Cancer Center, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT06425926

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

U tijeku regrutacijaFaza 1/2
  • University of Cincinnati, Cincinnati
Od 18 do 70 godina · Oba spola · Ažurirano 11. lip 2026. · NCT05361174

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

U tijeku regrutacijaFaza 1/2
  • University of Cincinnati Cancer Center, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 8. lip 2026. · NCT03947385

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

U tijeku regrutacijaFaza 1/2
  • Christ Hospital Cancer Center, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 15. svi 2026. · NCT05379985

Promoting Immunotherapy Efficacy With Low-Dose Liver RT

U tijeku regrutacija
  • University of Cincinnati Medical Center, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 27. velj 2026. · NCT07225036

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

U tijeku regrutacijaFaza 3
  • St Elizabeth Healthcare (St Elizabeth Medical Center), Edgewood · 8 mi udaljenosti
  • St Elizabeth Healthcare (St Elizabeth Medical, Edgewood · 8 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT05549297

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

U tijeku regrutacijaFaza 1/2
  • Research Site 113, Cincinnati
Od 18 godina i više · Oba spola · Ažurirano 21. stu 2025. · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

U tijeku regrutacijaOpažajna studija
  • Massive Bio SYNERGY-AI site, Cincinnati
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

U tijeku regrutacija
  • University of Cincinnati, Cincinnati
  • West Chester Hospital (OH394), West Chester · 15 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 27. stu 2024. · NCT03860883

Studije za Melanom u drugim gradovima

Ostale studije u gradu Cincinnati

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.